CIK 1594954
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2017-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 45.29% | 35 |
| Pharmaceuticals & Biotechnology | 20.88% | 10 |
| Life Sciences Tools & Services | 8.14% | 1 |
| Commercial Services & Supplies | 4.28% | 1 |
| Specialty Retail | 4.23% | 2 |
| Chemicals | 3.65% | 4 |
| Food Products | 3.02% | 4 |
| Paper & Forest Products | 2.85% | 1 |
| Distributors | 2.53% | 1 |
| Beverages | 2.13% | 2 |
| Health Care Providers & Services | 1.41% | 1 |
| Hotels, Restaurants & Leisure | 1.26% | 1 |
| Health Care Equipment & Supplies | 0.31% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | GW PHARMACEUTICALS PLC | Unclassified | 9.36% | |
| 2 | INCY | INCYTE CORP | Health Care | 8.14% |
| 3 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Health Care | 5.76% |
| 4 | TESARO INC. | Unclassified | 4.67% | |
| 5 | CLOVIS ONCOLOGY INC | Unclassified | 4.49% | |
| 6 | BABA | Alibaba Group Holding Ltd | Industrials | 4.28% |
| 7 | PBYI | PUMA BIOTECHNOLOGY, INC. | Health Care | 3.43% |
| 8 | PLCE | Childrens Place, Inc. | Consumer Discretionary | 3.25% |
| 9 | IBB | ISHARES TR | Unclassified | 3.06% |
| 10 | INTERCEPT PHARMACEUTICALS IN | Unclassified | 2.94% |
29/64 names classified · sector 54.7% of weight · industry 54.7% · mkt cap 48.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 54.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 44% of book weight classified — the grid is NOT representative of the whole book.
Classified: 44.2% of book weight (22/35 names) · unclassified 55.8%: , BABA, IBB, BUD, SCYX, SRPT, INSM, ESPR, QURE, GDX +3 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | GW PHARMACEUTICALS PLC | 36,847 | $4M | 9.4% | ADD 10% |
| 2 | INCYINCYTE CORP | 27,887 | $3M | 8.1% | NEW |
| 3 | TEVATEVA PHARMACEUTICAL INDS LTD | 130,723 | $2M | 5.8% | NEW |
| 4 | TESARO INC. | 14,462 | $2M | 4.7% | ADD 34% |
| 5 | CLOVIS ONCOLOGY INC | 21,787 | $2M | 4.5% | TRIM −48% |
| 6 | BABAALIBABA GROUP HLDG LTD | 9,900 | $2M | 4.3% | HOLD |
| 7 | PBYIPUMA BIOTECHNOLOGY INC | 11,438 | $1M | 3.4% | NEW |
| 8 | PLCECHILDRENS PL INC NEW | 11,000 | $1M | 3.3% | NEW |
| 9 | IBBISHARES TR | 3,662 | $1M | 3.1% | TRIM −46% |
| 10 | INTERCEPT PHARMACEUTICALS IN | 20,264 | $1M | 2.9% | NEW |
| 11 | KMBKIMBERLY-CLARK CORP | 9,700 | $1M | 2.9% | NEW |
| 12 | NKENIKE INC | 20,400 | $1M | 2.6% | NEW |
| 13 | HSICHENRY SCHEIN INC | 12,348 | $1M | 2.5% | NEW |
| 14 | ZOGENIX INC. | 26,778 | $939,000 | 2.3% | NEW |
| 15 | GILDGILEAD SCIENCES INC | 11,581 | $938,000 | 2.3% | NEW |
| 16 | ALEXION PHARMACEUTICALS INC | 6,518 | $914,000 | 2.3% | NEW |
| 17 | BUDANHEUSER BUSCH INBEV SA/NV | 7,100 | $847,000 | 2.1% | HOLD |
| 18 | ABTABBOTT LABS | 15,800 | $843,000 | 2.1% | TRIM −68% |
| 19 | DBV TECHNOLOGIES S A | 18,524 | $786,000 | 2.0% | NEW |
| 20 | MDLZMONDELEZ INTL INC | 17,700 | $720,000 | 1.8% | TRIM −47% |
| 21 | TIME WARNER INC | 6,445 | $660,000 | 1.7% | ADD 163% |
| 22 | SCYXSCYNEXIS INC COM NEW | 241,236 | $581,000 | 1.5% | HOLD |
| 23 | AIMMUNE THERAPEUTICS INC. | 23,100 | $573,000 | 1.4% | NEW |
| 24 | SRPTSAREPTA THERAPEUTICS INC | 12,522 | $568,000 | 1.4% | TRIM −22% |
| 25 | DVADaVita HealthCare Partners, Inc. | 9,500 | $564,000 | 1.4% | TRIM −35% |
| 26 | INSMINSMED INC | 17,953 | $560,000 | 1.4% | HOLD |
| 27 | REGNREGENERON PHARMACEUTICALS | 1,250 | $559,000 | 1.4% | ADD 90% |
| 28 | AXOVANT SCIENCES LTD | 74,670 | $514,000 | 1.3% | ADD 661% |
| 29 | QSRRESTAURANT BRANDS INTL INC | 7,900 | $505,000 | 1.3% | NEW |
| 30 | ABBVABBVIE INC | 5,403 | $480,000 | 1.2% | NEW |
| 31 | CASCADIAN THERAPEUTICS INC | 115,206 | $471,000 | 1.2% | TRIM −10% |
| 32 | ESPRESPERION THERAPEUTICS INC NE | 8,825 | $442,000 | 1.1% | NEW |
| 33 | WMTWALMART INC | 5,000 | $391,000 | 1.0% | NEW |
| 34 | CLXCLOROX CO DEL | 2,400 | $317,000 | 0.8% | TRIM −75% |
| 35 | PTCTPTC THERAPEUTICS INC | 14,323 | $287,000 | 0.7% | NEW |
| 36 | GISGENERAL MILLS INC | 5,000 | $259,000 | 0.6% | TRIM −90% |
| 37 | AERIE PHARMACEUTICALS INC | 5,060 | $246,000 | 0.6% | ADD 16% |
| 38 | VERSARTIS INC | 91,440 | $224,000 | 0.6% | NEW |
| 39 | NEWLINK GENETICS CORP | 20,796 | $212,000 | 0.5% | NEW |
| 40 | QUREUNIQURE NV | 21,597 | $207,000 | 0.5% | TRIM −48% |
| 41 | SAGE THERAPEUTICS INC COM | 2,957 | $184,000 | 0.5% | TRIM −70% |
| 42 | KELLANOVA | 2,800 | $175,000 | 0.4% | TRIM −84% |
| 43 | NABRIVA THERAPEUTICS PLC | 20,000 | $164,000 | 0.4% | ADD 32% |
| 44 | LA JOLLA PHARMACEUTICAL CO | 4,560 | $159,000 | 0.4% | NEW |
| 45 | KHCKRAFT HEINZ CO | 2,000 | $155,000 | 0.4% | NEW |
| 46 | OTONOMY INC | 45,101 | $147,000 | 0.4% | TRIM −23% |
| 47 | ZYNERBA PHARMACEUTICALS INC | 17,500 | $146,000 | 0.4% | ADD 600% |
| 48 | FOOT LOCKER INC | 4,000 | $141,000 | 0.4% | NEW |
| 49 | GDXVANECK ETF TRUST GOLD MINERS ETF | 5,765 | $132,000 | 0.3% | NEW |
| 50 | DXCMDEXCOM | 2,500 | $122,000 | 0.3% | NEW |
| 51 | POTASH CORP OF SASKATCHEWAN | 6,300 | $121,000 | 0.3% | TRIM −84% |
| 52 | FIBROCELL SCIENCE INC | 38,001 | $116,000 | 0.3% | NEW |
| 53 | ZAFGEN INC | 25,653 | $90,000 | 0.2% | TRIM −58% |
| 54 | SVVCFIRSTHAND TECHNOLOGY VALUE F | 11,000 | $88,000 | 0.2% | TRIM −45% |
| 55 | TETRAPHASE PHARMACEUTICALS INC | 12,000 | $82,000 | 0.2% | NEW |
| 56 | HAINHAIN CELESTIAL GROUP INC | 1,800 | $74,000 | 0.2% | TRIM −82% |
| 57 | PARATEK PHARMACEUTICALS INC | 2,748 | $69,000 | 0.2% | NEW |
| 58 | CLCOLGATE PALMOLIVE CO | 900 | $66,000 | 0.2% | TRIM −93% |
| 59 | Adobe Systems Inc | 60,000 | $49,000 | 0.1% | HOLD |
| 60 | JUNO THERAPEUTICS INC | 1,000 | $45,000 | 0.1% | NEW |
| 61 | GGP INC | 1,757 | $36,000 | 0.1% | NEW |
| 62 | Rocket Pharmaceuticals Inc | 20,000 | $36,000 | 0.1% | TRIM −87% |
| 63 | MOSMOSAIC CO NEW | 933 | $20,000 | 0.1% | NEW |
| 64 | CCEPCOCA-COLA EUROPACIFIC PARTNE | 100 | $4,000 | 0.0% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
